Scientists collect kidney samples from COVID-19 patients to uncover clues about organ damage

NCT ID NCT05384899

Completed Knowledge-focused Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study collected blood, urine, and kidney tissue from 90 COVID-19 patients with acute kidney injury. Researchers aimed to build a biorepository and analyze samples to better understand how COVID-19 affects the kidneys. The goal is to speed up discoveries and improve treatments for kidney complications related to COVID-19.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help scientists discover new treatments for kidney complications in COVID-19 patients.
What could go wrong: This is an observational study that does not test any treatment directly, so it may not lead to immediate medical advances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY FAILURE ACUTE KIDNEY INSUFFICIENCY ACUTE RENAL FAILURE ACUTE RENAL INJURY ACUTE RENAL INSUFFICIENCY COVID19 KIDNEY FAILURE, ACUTE KIDNEY INSUFFICIENCY, ACUTE RENAL FAILURE, ACUTE RENAL INSUFFICIENCY, ACUTE SARS-COV-2 INFECTION

Contacts and locations

Show contact details

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 48374, United States
Johns Hopkins University

Baltimore, Maryland, 21287, United States
University of Texas at Southwestern

Dallas, Texas, 75390, United States
Yale University

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.